Anges Inc Stock Analysis
| AMGXF Stock | USD 0.36 0.00 0.00% |
AnGes' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. AnGes' financial risk is the risk to AnGes stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that AnGes' debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which AnGes is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of AnGes to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, AnGes is said to be less leveraged. If creditors hold a majority of AnGes' assets, the OTC Stock is said to be highly leveraged.
AnGes Inc is overvalued with Real Value of 0.3 and Hype Value of 0.36. The main objective of AnGes otc analysis is to determine its intrinsic value, which is an estimate of what AnGes Inc is worth, separate from its market price. There are two main types of AnGes' stock analysis: fundamental analysis and technical analysis.
The AnGes otc stock is traded in the USA on OTCGREY Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AnGes' ongoing operational relationships across important fundamental and technical indicators.
AnGes |
AnGes OTC Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. AnGes Inc recorded a loss per share of 0.65. The entity had not issued any dividends in recent years. AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.The quote for AnGes Inc is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on AnGes Inc go to https://www.anges.co.jp.AnGes Inc Investment Alerts
| AnGes Inc generated a negative expected return over the last 90 days | |
| AnGes Inc has some characteristics of a very speculative penny stock | |
| AnGes Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 64.15 M. Net Loss for the year was (13.68 B) with loss before overhead, payroll, taxes, and interest of (26 M). | |
| AnGes Inc has accumulated about 13.21 B in cash with (11.38 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 86.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
AnGes Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 159.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AnGes's market, we take the total number of its shares issued and multiply it by AnGes's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
AnGes Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated zero technical drivers for AnGes Inc, which can be compared to its peers.AnGes Inc Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AnGes middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AnGes Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
AnGes Inc Debt to Cash Allocation
Many companies such as AnGes, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has a current ratio of 1.93, which is within standard range for the sector. Debt can assist AnGes until it has trouble settling it off, either with new capital or with free cash flow. So, AnGes' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AnGes Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AnGes to invest in growth at high rates of return. When we think about AnGes' use of debt, we should always consider it together with cash and equity.AnGes Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the AnGes' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of AnGes, which in turn will lower the firm's financial flexibility.About AnGes OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how AnGes prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AnGes shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as AnGes. By using and applying AnGes OTC Stock analysis, traders can create a robust methodology for identifying AnGes entry and exit points for their positions.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding AnGes to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Complementary Tools for AnGes OTC Stock analysis
When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |